John Shine
Corporate Officer/Principal bij The University of New South Wales
Actieve functies van John Shine
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| The University of New South Wales | Corporate Officer/Principal | 29-10-2010 | - |
Loopbaan van John Shine
Eerdere bekende functies van John Shine
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CSL LIMITED | Directeur/Bestuurslid | 01-06-2006 | 03-02-2011 |
| Voorzitter | 19-10-2011 | 17-10-2018 | |
| Independent Dir/Board Member | 03-02-2011 | 19-10-2011 | |
The Garvan Institute of Medical Research
 The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia. | Directeur/Bestuurslid | 29-10-2010 | 01-01-2012 |
| Museum of Applied Arts & Sciences | President | - | - |
| Prime Minister's Science, Engineering & Innovation Council | Corporate Officer/Principal | - | - |
| National Health & Medical Research Council | Voorzitter | - | - |
| Garvan Research Foundation | Directeur/Bestuurslid | 02-02-2011 | - |
G2 Therapies Pty Ltd.
 G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | Directeur/Bestuurslid | 29-10-2010 | - |
Statistieken
Internationaal
| Australië | 9 |
Operationeel
| Director/Board Member | 4 |
| Chairman | 2 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CSL LIMITED | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
G2 Therapies Pty Ltd.
G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | Health Technology |
The Garvan Institute of Medical Research
The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Garvan Institute of Medical Research engages in the provision of biomedical research. It focuses in cancer, genomics and epigenetics, immunity and inflammation, healthy ageing, clinical trials, and research centres. The company was founded in 1963 and is headquartered in Darlinghurst, Australia. | Commercial Services |
| Garvan Research Foundation | |
| National Health & Medical Research Council | Government |
| Prime Minister's Science, Engineering & Innovation Council | |
| Museum of Applied Arts & Sciences |
- Beurs
- Insiders
- John Shine
- Ervaring
